| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5874100 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 9 Pages |
Abstract
5-hydroxytryptamine receptor 1A (5HT1A) agonists significantly reduce infarct volumes in MCAO rats primarily because of the hypothermic drug effect. 5HT1A agonists may be introduced to reduce body temperatures rapidly and prepare patients for further therapeutic hypothermia.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Flemming Fryd MD, DMSc, Henrik MSc, PhD, Matthias MS, Rune Skovgaard MA, PhD,